Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Phase 2a, Double-Blind, Placebo-controlled Randomized Trial of Inhaled TLR9 Agonist AZD1419 in Asthma.
Psallidas I, Backer V, Kuna P, Palmér R, Necander S, Aurell M, Korsback K, Taib Z, Hashemi M, Gustafson P, Asimus S, Delaney S, Pardali K, Jiang F, Almquist J, Jackson S, Coffman RL, Keeling D, Sethi T. Psallidas I, et al. Among authors: taib z. Am J Respir Crit Care Med. 2021 Feb 1;203(3):296-306. doi: 10.1164/rccm.202001-0133OC. Am J Respir Crit Care Med. 2021. PMID: 32809843 Clinical Trial.
The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial.
Patel NR, Cunoosamy DM, Fagerås M, Taib Z, Asimus S, Hegelund-Myrbäck T, Lundin S, Pardali K, Kurian N, Ersdal E, Kristensson C, Korsback K, Palmér R, Brown MN, Greenaway S, Siew L, Clarke GW, Rennard SI, Make BJ, Wise RA, Jansson P. Patel NR, et al. Among authors: taib z. Int J Chron Obstruct Pulmon Dis. 2018 Mar 27;13:1009-1019. doi: 10.2147/COPD.S150576. eCollection 2018. Int J Chron Obstruct Pulmon Dis. 2018. PMID: 29628759 Free PMC article. Clinical Trial.
Feasibility assessment of using oxygen-enhanced magnetic resonance imaging for evaluating the effect of pharmacological treatment in COPD.
Morgan AR, Parker GJ, Roberts C, Buonaccorsi GA, Maguire NC, Hubbard Cristinacce PL, Singh D, Vestbo J, Bjermer L, Jögi J, Taib Z, Sarv J, Bruijnzeel PL, Olsson LE, Bondesson E, Nihlén U, McGrath DM, Young SS, Waterton JC, Nordenmark LH. Morgan AR, et al. Among authors: taib z. Eur J Radiol. 2014 Nov;83(11):2093-101. doi: 10.1016/j.ejrad.2014.08.004. Epub 2014 Aug 17. Eur J Radiol. 2014. PMID: 25176287
Study on risk factors and phenotypes of acute exacerbations of chronic obstructive pulmonary disease in Guangzhou, China-design and baseline characteristics.
Zhou Y, Bruijnzeel PL, McCrae C, Zheng J, Nihlen U, Zhou R, Van Geest M, Nilsson A, Hadzovic S, Huhn M, Taib Z, Gu Y, Xie J, Ran P, Chen R, Zhong N. Zhou Y, et al. Among authors: taib z. J Thorac Dis. 2015 Apr;7(4):720-33. doi: 10.3978/j.issn.2072-1439.2015.04.14. J Thorac Dis. 2015. PMID: 25973239 Free PMC article.
Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes.
Mesquita R, Vanfleteren LE, Franssen FM, Sarv J, Taib Z, Groenen MT, Gaffron S, Bruijnzeel PL, Pitta F, Wouters EF, Spruit MA. Mesquita R, et al. Among authors: taib z. Eur Respir J. 2015 Aug;46(2):545-8. doi: 10.1183/09031936.00026215. Epub 2015 Jun 25. Eur Respir J. 2015. PMID: 26113670 Free article. No abstract available.
18 results